Evolve Private Wealth’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$717K Buy
7,706
+677
+10% +$60K 0.04% 431
2025
Q4
$565K Buy
+7,029
New +$589K 0.03% 486

Other funds holding ACLS

Evolve Private Wealth's ACLS Position: Q1 2026 in Review

Evolve Private Wealth increased its Axcelis (ACLS) stake by 9.6% in Q1 2026, buying an estimated $60K and bringing the position to 7,706 shares worth $717K. The position accounts for 0.04% of the portfolio, ranked #431.

Evolve Private Wealth first reported a position in ACLS in Q4 2025 and has held it in 2 quarters since. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • Evolve Private Wealth held 7,706 shares of Axcelis worth $717K as of Q1 2026.
  • Evolve Private Wealth bought 677 Axcelis shares in Q1 2026, an estimated $60K.
  • Axcelis made up 0.04% of Evolve Private Wealth's portfolio in Q1 2026, its #431 holding.
  • Evolve Private Wealth first reported a position in Axcelis in Q4 2025 and has held it in 2 quarters since.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on Evolve Private Wealth's 13F filing for Q1 2026, filed 16 Apr 2026.